Hogehilweg 18 Mon-Fri 08:30-17:30
MijnMedicijn
📞 Contact phone — free, 24/7

Order Requip safely online in the Netherlands

Ropinirole

★★★★☆ 4.5 (224 reviews)
In stock — ready for delivery today
Choose dosage and pack size
PackagePrice per DosePrice
360 pills€0,95
€381,69
€343,52
Free shipping
180 pills€0,98
€196,72
€177,05
120 pills€1,04
€139,55
€125,60
90 pills€1,10
€110,97
€99,87
60 pills€1,21
€80,70
€72,63
30 pills€1,42
€47,07
€42,36
360 pills€1,21
€482,59
€434,33
Free shipping
180 pills€1,27
€253,90
€228,51
Free shipping
120 pills€1,39
€184,95
€166,46
90 pills€1,51
€151,32
€136,19
60 pills€1,68
€112,65
€101,38
30 pills€2,01
€67,24
€60,52
360 pills€1,94
€775,17
€697,66
Free shipping
180 pills€2,12
€423,73
€381,36
Free shipping
120 pills€2,36
€314,43
€282,99
Free shipping
90 pills€2,60
€260,62
€234,56
Free shipping
60 pills€2,97
€198,41
€178,56
30 pills€3,59
€119,37
€107,44
360 pills€2,42
€968,55
€871,70
Free shipping
180 pills€2,74
€548,17
€493,35
Free shipping
120 pills€3,12
€415,32
€373,79
Free shipping
90 pills€3,48
€348,06
€313,26
Free shipping
60 pills€4,21
€280,80
€252,72
Free shipping
30 pills€5,66
€188,32
€169,48
€343,52
Quantity:
✈️
Airmail 14–21 days
⚡
Express delivery 5–9 days
🎁
Free Airmail from €182,34
🔒
Crypto discount −10%

Disclaimer: This information is intended for adults and may require a prescription depending on local rules. It is not a substitute for professional medical advice from a pharmacist or doctor.

What Requip is and what it contains

Requip is the brand name for ropinirole, a dopamine agonist used to treat symptoms of Parkinson’s disease and restless legs syndrome. The active ingredient is ropinirole, which functions by stimulating dopamine receptors in the brain to help control movement and reduce uncomfortable sensations. In the Netherlands, the medicine is provided as tablets in different strengths and formulations, prescribed by a clinician and dispensed by a pharmacist. The product information leaflet explains the exact composition, fillers, and any potential issues related to the tablet formulation.

The primary purpose of ropinirole is to compensate for reduced natural dopamine activity in the brain, thereby improving motor function in Parkinson’s disease and reducing sensory urges in restless legs syndrome. It may be prescribed as a stand-alone therapy or as part of a broader treatment plan that includes other Parkinson’s medications. A healthcare professional will determine the appropriate formulation and dosing sequence based on individual needs and response to therapy.

The medication should be used under professional supervision, with attention to potential interactions and side effects. Patients are advised to read the official patient information leaflet supplied with the product and to discuss any questions with a pharmacist or prescriber. If there is any uncertainty about the medication’s purpose or safety, check the leaflet or speak with a healthcare professional before use.

The following background information helps set expectations for treatment with ropinirole and is not a guarantee of effect for any individual. The time to benefit, potential risks, and the need for ongoing monitoring will be explained by the prescriber, who will tailor therapy to the patient’s condition, tolerability, and concomitant medications.

Conditions and symptoms ropinirole may treat

Ropinirole is approved to treat two main conditions in adults: Parkinson’s disease and restless legs syndrome. Each condition presents with characteristic symptoms that may be improved by therapy. The medication is selected when symptoms interfere with daily activities or sleep, and a clinician will assess whether ropinirole is appropriate.

Parkinson’s disease typically presents with movement-related symptoms such as tremor, slowness of movement, stiffness, and impaired balance or coordination. These features may affect walking, fine motor tasks, and the ability to carry out daily activities. Ropinirole is used to help improve motor control and reduce the impact of these symptoms on function.

Restless legs syndrome is characterized by an unpleasant urge to move the legs, often accompanied by uncomfortable sensations, particularly in the evening or at night. Symptoms can delay sleep and lead to daytime fatigue. Ropinirole may reduce the urge to move and improve sleep quality in affected individuals.

The following symptoms are commonly considered when evaluating ropinirole therapy: changes in sleep quality, improvement in daytime activity, reductions in tremor or stiffness, and enhanced ability to perform routine tasks. A clinician will monitor response and adjust the treatment plan as needed. If there is any doubt about symptom control or changes in symptoms, contact the prescribing professional for guidance.

How ropinirole works in the body (mechanism of action)

The mechanism of action of ropinirole involves stimulation of dopamine receptors in the brain, specifically dopamine D2-like receptors, which helps to compensate for reduced dopamine signaling in Parkinson’s disease and modulates sensory-motor pathways involved in restless legs syndrome. This stimulation is intended to improve motor function and reduce abnormal limb sensations or urges to move. The effect is achieved by acting on central nervous system pathways that regulate movement and sensory perception.

Ropinirole belongs to the class of medications known as dopamine agonists; these drugs mimic the action of natural dopamine at receptor sites. The net result is improved communication between nerve cells that govern movement, posture, and sleep-related control of leg sensations. As with other dopaminergic therapies, the exact pattern of benefit can vary among individuals, and therapeutic response often develops over weeks of consistent use.

In pharmacological terms, ropinirole tends to have a high affinity for D2-like receptors and produces downstream signaling that influences motor circuits. The medication is designed to provide symptomatic relief rather than a cure, and it is usually integrated into a broader management plan that may include other antiparkinsonian agents, physical therapy, and lifestyle adjustments. If any concerns arise about how the drug works, these should be discussed with a health professional.

Long-term treatment requires ongoing evaluation to ensure that the benefits continue to outweigh the risks and to detect any emerging adverse effects. The clinician may modify the formulation, dosage, or combination with other therapies based on the patient’s evolving needs and tolerance to therapy.

How to take ropinirole — dosage guidance, timing, and food considerations

Ropinirole is taken by mouth and is available in immediate-release and extended-release formulations; the exact product prescribed will depend on the condition being treated and the patient’s response. The dosing schedule is individualized and will be adjusted by a clinician to achieve symptom control while minimizing adverse effects. The medication should be taken exactly as prescribed, and any changes should be discussed with a pharmacist or prescriber.

Tablets are typically swallowed whole with water; do not crush or chew extended-release formulations unless explicitly advised by a healthcare professional, as altering the release mechanism can affect how the medicine works. The timing of doses and whether to take the medicine with or without food will be determined by the prescriber based on tolerability and absorption considerations.

In general, a gradual dose titration approach is used to find the lowest effective dose and to minimize side effects such as dizziness or nausea. Patients should not self-adjust doses or stop the medication abruptly without medical guidance, as sudden changes can lead to withdrawal effects or a quick return of symptoms. If a dose is missed, the patient should consult the pharmacist or prescriber for instructions rather than taking a double dose to make up for the missed one.

Practical considerations include adherence to a consistent schedule, especially when multiple daily doses are specified, and the avoidance of abrupt changes in activity or concurrent use of other sedating agents without medical advice. If nausea or lightheadedness occurs, it may be advised to take the medication with a small snack or to adjust the dosing pattern under professional supervision. Official patient information should be consulted for formulation-specific guidance.

People who should not take ropinirole — contraindications

Contraindications are conditions or circumstances in which ropinirole should not be used because the risk of harm may outweigh potential benefits. A clinician will verify contraindications before starting therapy. Known hypersensitivity to ropinirole or any ingredient in the tablet formulation is a primary contraindication.

Concomitant use of non-selective monoamine oxidase inhibitors (MAOIs) is generally avoided, as serious interactions can occur; if such therapy has been used, a clinician will determine the appropriate timing before starting ropinirole. Other absolute contraindications are uncommon, but certain psychiatric conditions or severe cognitive impairment may require careful consideration and monitoring rather than universal exclusion.

People with a history of psychosis or certain impulse control disorders related to medications may require special assessment, as ropinirole can influence behavior in some individuals. In the event of a known allergy to ropinirole ingredients or a related medication, the treatment should not be initiated without an alternative plan. The official leaflet should be consulted for a complete list of contraindications.

In pregnancy or breastfeeding, ropinirole use is typically considered only if the potential benefit justifies potential risk and after careful discussion with a clinician; however, the safety profile in pregnancy and lactation is not fully established, so alternatives are often preferred unless advised otherwise by a healthcare professional. Patients who are pregnant, planning pregnancy, or breastfeeding should seek individualized medical advice before starting therapy.

Warnings and precautions during ropinirole treatment

Warnings focus on potential adverse effects and situations requiring closer monitoring, such as hypotension, dizziness, and sudden sleep episodes. It is important to monitor blood pressure and gait stability, particularly after dose changes or during activities requiring alertness. A healthcare professional should be contacted if fainting, severe dizziness, or persistent confusion occur.

Impulse control disorders, including compulsive gambling, eating, shopping, or sexual activities, have been reported with dopamine agonists and ropinirole may exacerbate these conditions in some individuals. Such changes should be discussed promptly with a clinician, and treatment may need adjustment or discontinuation if these behaviors develop. The decision will be individualized and based on risk-benefit considerations.

Postural hypotension and dizziness are more common after dose increases or when standing up quickly; patients are advised to rise slowly from sitting or lying positions and to avoid driving or operating machinery if alertness is impaired. Sleep-related disorders, such as sudden sleep onset, can occur with dopamine agonists and may necessitate temporary cessation of activity that requires full attention. Medical advice should be sought for any concerning symptoms.

Other important precautions include avoiding abrupt discontinuation, as withdrawal symptoms or a rapid return of Parkinsonian symptoms may occur; immunologic reactions may present as skin rash or swelling in rare cases, requiring medical evaluation and possible drug discontinuation. The medication should be used with caution in patients with liver impairment, and liver function tests may be considered as part of ongoing safety monitoring when indicated by liver status or concomitant therapies.

Possible side effects of ropinirole

Most people tolerate ropinirole well, but side effects can occur. Common adverse effects include nausea, dizziness, sleepiness, dry mouth, constipation, and fatigue; some symptoms tend to improve as treatment continues or after dose adjustments. A clinician can help manage these effects through dose changes, timing adjustments, or supportive care.

More serious but less common adverse effects may include fainting, swelling of the legs or feet, mood changes, confusion, or unusual movements that are not typical for Parkinsonian tremor. If severe or persistent symptoms occur, medical evaluation should be sought promptly to determine whether dose adjustments or additional treatment is necessary.

Allergic reactions are uncommon but possible; signs may include swelling of the face or throat, skin rash, or severe itching. Any signs of an allergic reaction require immediate medical attention. If a skin rash or hives develops, the prescriber should be informed to determine whether the medication should be continued.

Long-term therapy requires ongoing safety monitoring to detect rare events such as dyskinesias, mood changes, or excessive daytime sleepiness. The prescribing clinician will decide on the appropriate monitoring plan, which may include follow-up visits and periodic assessment of symptoms and adverse effects. If there is uncertainty about a reported side effect, contact a pharmacist or prescriber for guidance.

Interactions with other medications, foods, and supplements

Ropinirole can interact with a number of other medicines, potentially altering effectiveness or increasing adverse effects. Interactions are more likely with other dopaminergic drugs, antipsychotics, or medicines that affect blood pressure or central nervous system function. A clinician will review all current medications to minimize risk.

Alcohol may enhance drowsiness or dizziness in some people taking ropinirole, and samplings of memory, attention, or reaction time might be affected. It is advisable to discuss alcohol use with a prescriber and to avoid driving if daytime sleepiness occurs. The information leaflet provides more detailed guidance on consumption limits and safety considerations.

Non-prescription products, including certain vitamins and herbal supplements, may interact with ropinirole; therefore, it is prudent to inform the pharmacist about all substances being used. Antidepressants, antiemetics, or other central nervous system agents can alter the effect or safety profile of ropinirole, so professional guidance is recommended when starting, stopping, or changing such therapies.

All potential interactions should be reviewed before initiating therapy, and any new medication or supplement should be disclosed to a healthcare professional promptly. If a dose adjustment is required due to interactions, a clinician will provide instructions tailored to the individual situation. In the Netherlands, local guidelines and the official patient information leaflet should be consulted for up-to-date interaction information.

Use during pregnancy and breastfeeding

Limited data are available on ropinirole use during pregnancy, and it is generally advised that treatment choices during pregnancy be made after careful discussion of potential risks and benefits with a clinician. If pregnancy occurs or is planned, a healthcare professional will reassess the treatment plan and consider alternative options if possible. The decision depends on the severity of the condition and the availability of other therapies.

Breastfeeding while taking ropinirole is not well established in terms of safety for the infant; if breastfeeding is anticipated, this topic should be discussed with a clinician or pharmacist before starting therapy. In some cases, the clinician may recommend stopping breastfeeding or choosing a different treatment approach to minimize exposure to the infant.

When pregnancy or lactation is a possibility, the medication must be used only under medical supervision. The healthcare professional will weigh the potential benefits for the mother against the potential risks to the fetus or infant and adjust the regimen accordingly. If pregnancy occurs during treatment, seek urgent medical advice for guidance on continuing therapy safely.

In all cases, consult the official patient information leaflet and coordinate care with obstetricians, neurologists, or other involved healthcare professionals to ensure the safest course of action for both mother and child. If there is any doubt, the reader should consult a healthcare professional for personalized recommendations.

Frequently asked questions about ropinirole (Requip)

Can I expect to feel improvements quickly after starting ropinirole?

Some people notice benefits within a few weeks, while others may require longer before a clear response is observed. The speed of improvement depends on the individual and the condition being treated, as well as the chosen formulation and dose schedule. If no meaningful benefit is seen after several weeks, a clinician may consider adjusting the dose or formulation. For any persistent concerns, an appointment should be scheduled with the prescriber or a pharmacist.

What should be done if a dose is missed?

If a dose is missed, guidance should be sought from the prescribing clinician or pharmacist; do not double the next dose unless advised to do so. The timing of the next dose should be resumed according to the prescribed schedule, and any questions about missed doses should be addressed by a healthcare professional to minimize disruption of symptom control and safety.

Is it safe to drink alcohol while taking ropinirole?

Alcohol may interact with ropinirole and increase dizziness or drowsiness in some individuals; caution is advised when consuming alcohol during treatment. If alcohol consumption leads to noticeable changes in alertness or balance, it should be discussed with a clinician. The decision on alcohol use should be tailored to the patient’s tolerance and medical history.

How long should therapy continue?

The duration of treatment is individualized and depends on the clinical response and tolerability. In some cases, long-term therapy is necessary to maintain symptom control, while periodic reviews with a clinician determine whether continued therapy remains appropriate. Decisions about continuing, stopping, or delaying treatment are made in collaboration with a healthcare professional.

Is ropinirole safe to use for many years?

Long-term use can be appropriate for some patients under close medical supervision, but ongoing monitoring is essential to identify any evolving side effects or changes in symptoms. The risk-benefit profile should be reassessed periodically, and therapy should be adjusted if risks outweigh benefits. The clinician will provide recommended monitoring and follow-up intervals.

What should be done if dizziness or fainting occurs?

Dizziness or fainting may emerge after dose changes or with standing; rising slowly from sitting or lying positions can reduce risk. If symptoms persist or are severe, a clinician should be contacted to determine whether dose adjustments are needed or if additional evaluation is required. Urgent medical attention should be sought if fainting is accompanied by other concerning symptoms.

Can driving or operating heavy machinery be affected by ropinirole?

Ropinirole can cause drowsiness or dizziness in some individuals, particularly after initiating therapy or increasing the dose. If alertness is impaired, activities requiring full attention should be postponed until clarity is regained. A clinician should be informed if such effects interfere with daily activities or safety considerations.

Are there specific signs that indicate impulse control problems?

Unusual urges, compulsive behaviors such as gambling, binge eating, or excessive spending, may occur; if these behaviors develop, they should be reported to a clinician promptly. Treatment decisions may include dose adjustment or switching to an alternative therapy to manage these effects safely. Early communication with a healthcare professional is advised if such symptoms are observed.

What should be done regarding food and drug interactions?

Food generally does not require strict timing adjustments, but certain medicines or supplements can interact with ropinirole; always inform the pharmacist about all substances being taken. A clinician can provide personalized guidance on minimizing interactions and may adjust therapy if needed. If any new medication is started, seek professional advice about potential interactions with ropinirole.

How should storage and disposal be handled?

Store ropinirole at room temperature, away from moisture and heat, and keep it out of reach of children. Do not use medications beyond their expiry date and follow local guidelines for disposal if medication is no longer needed. For specific storage instructions, consult the product leaflet or ask a pharmacist for advice.

Where to find more information — official leaflets and healthcare providers

The primary source of information is the official patient information leaflet supplied with the medication; it contains detailed instructions on dosing, administration, contraindications, interactions, and safety warnings. The leaflet also lists excipients, storage requirements, and steps to take in case of missed doses or accidental exposure. If the leaflet is not available in the current format, the pharmacist or prescriber can provide a copy or summary of essential information.

Further guidance can be obtained by discussing the treatment with a pharmacist, community health center, or the prescribing clinician. Pharmacists are trained to explain how ropinirole should be taken, to review potential interactions with other medicines, and to help manage side effects or dose changes safely. When in doubt, contact a healthcare professional for tailored advice based on medical history and current therapies.

In the Netherlands, national pharmacovigilance resources and the official drug information for ropinirole may be referenced for updates on safety in clinical practice. If new symptoms or concerns arise, promptly notify a clinician or pharmacist so that a safe course of action can be determined. The patient is encouraged to maintain a current list of medications and to bring it to every healthcare appointment to support shared decision making and safe prescribing.

Readers are advised to consult the most recent official leaflets and to seek personalised guidance from their doctor or pharmacist for country-specific instructions, restrictions, and recommendations. For any unexpected or severe symptoms, seek urgent medical help and report the issue through the appropriate channels. The information provided here is intended to support, not replace, professional medical care.

✈️

Airmail

14–21 days. Free from €182,34 .

⚡

Express delivery

5–9 days. €27,35

🔒

Crypto discount

−10% when paying with cryptocurrency.

🔄

Reorder discount

−10% on all repeat orders.

📦 Packaging and discretion

All orders are packed in neutral, unbranded boxes with no product name on the outside.

Jeroen van den Berg
Medically reviewed by
Jeroen van den Berg
Registered Pharmacist (Apotheker), Chief Pharmacist and Head of Pharmacy Department